Skip to main content

International Cancer Conference Journal OnlineFirst articles

22.04.2024 | Case Report - Complication

An underrecognized association: immune checkpoint inhibitor-related aortitis, a case report with the review of the literature

Immune-checkpoint inhibitors (ICIs) are considered as the novel treatment modality in certain cancers. They may soon be used widely even as the first-line option for cancer treatment due to their remarkable efficacies and impacts on survival …

verfasst von:
Reşit Yıldırım, Aida Shikhaliyeva, Hüseyin İçer, Hakan Deveci, Emre Entok, Döndü Üsküdar Cansu, Cengiz Korkmaz

22.04.2024 | Case Report - Surgery

Successful curative treatment for a ruptured pancreatic acinar cell carcinoma by radical resection following modified FOLFIRINOX: a case report and literature review

Pancreatic acinar cell carcinoma (PACC) is a rare pancreatic tumor type, and ruptured pancreatic tumors are rarer. Computed tomography (CT) in a 48-year-old man incidentally revealed a raptured pancreatic tail tumor. The patient was treated …

verfasst von:
Kei Yamane, Kosuke Tsukano, Yosuke Umino, Tadashi Nagami, Koji Tarumoto, Kuniaki Hattori, Ryo Maemoto, Junji Iwasaki, Akiyoshi Kanazawa

22.04.2024 | Case Report - Pathology

Renal pelvic plasmacytoid subtype urothelial carcinoma accompanied with solitary mammary metastasis

A 72-year-old female was referred to our institution for further evaluation of right renal tumor detected during work-up for macroscopic hematuria in other hospital. CT urography performed at our institution suggested renal pelvic tumor. Voiding …

verfasst von:
Keisuke Matsubara, Nozomi Hayakawa, Koichiro Aida, Junki Koike, Eiji Kikuchi

Open Access 18.04.2024 | Case Report - Pathology

Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report

A 71-year-old man with bone metastasis of hormone-sensitive prostate cancer was treated with androgen deprivation therapy and apalutamide. Radium-223 and radiation therapy were administered after it become castration resistant. Although …

verfasst von:
Yusuke Hoshino, Kent Kanao, Yu Miyama, Takeo Kosaka, Go Kaneko, Suguru Shirotake, Masanori Yasuda, Masafumi Oyama

Open Access 18.04.2024 | Case Report - Molecularly Targeted Therapy

BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis

BRAF-mutant microsatellite-stable colorectal cancer (CRC), metastasized to distant sites, is associated with a poor prognosis. However, the BEACON CRC regimen, comprising a BRAF inhibitor, MEK inhibitor, and anti-EGFR antibody, offered a prolonged …

verfasst von:
Kunitoshi Shigeyasu, Hideki Yamamoto, Toshiaki Takahashi, Kazuya Moriwake, Masashi Kayano, Sho Takeda, Yuki Matsumi, Yuzo Umeda, Yoshitaka Kondo, Fuminori Teraishi, Kazuya Yasui, Tomokazu Fuji, Shunsuke Kagawa, Toshiyoshi Fujiwara

16.04.2024 | Case Report - Genetics

Multiple endocrine neoplasia type 1 with MEN1 variant of unknown significance, in a patient after the diagnosed of pancreatic neuroendocrine neoplasia

Duodenopancreatic neuroendocrine neoplasia (DP-NEN) is in approximately 10% of cases of multiple endocrine neoplasia type 1 (MEN1). We encountered a case in which the onset of NEN led to suspicion and diagnosis of MEN1. Although genetic testing …

verfasst von:
Yuko Tanaka, Takafumi Niitani, Takatsugu Matsumoto, Akihito Abe, Kazuyuki Ishida, Taku Aoki

13.04.2024 | Case Report - Complication

Significant improvement in paraneoplastic neurological syndromes without identifiable anti-neural antibodies in patients with breast cancer after breast surgery

Paraneoplastic neurological syndromes (PNS) are neurological disorders that occur in close association with tumors without direct metastasis or invasion of the tumors and in which anti-neural antibodies may be present. Cerebellar ataxia is a …

verfasst von:
Tomohiro Oshino, Karin Shikishima, Yumi Moriya, Kaede Ishikawa, Megumi Abe, Hiroaki Yaguchi, Mitsuchika Hosoda, Keiko Tanaka, Ichiro Yabe, Masato Takahashi

10.04.2024 | Case Report - Molecularly targeted therapy

Successful treatment of pediatric patients with high-grade gliomas featuring leptomeningeal metastases by targeting BRAF V600E mutations with dabrafenib plus trametinib: two illustrative cases

A combination of BRAF and MEK inhibitors is reported to be effective for gliomas with the BRAF V600E mutation; however, its efficacy in gliomas with leptomeningeal metastases (LMM) is still unknown. In this report, we describe two pediatric …

verfasst von:
Yuki Kawaguchi, Yuko Watanabe, Yasuji Miyakita, Makoto Ohno, Chitose Ogawa, Masamichi Takahashi, Shunsuke Yanagisawa, Takayuki Mukai, Hiroshi Igaki, Hirokazu Sugino, Akihiko Yoshida, Yoshitaka Narita

02.04.2024 | Case Report - Pathology

Disseminated AIDS-associated Kaposi sarcoma without cutaneous involvement: a case report and review of literature

Disseminated AIDS-associated Kaposi sarcoma (KS) without cutaneous lesions is rare and can present in varying ways. Diagnosis is even more challenging now when incidence of KS is on the decline. A high index of suspicion is required for early …

verfasst von:
Vera Mbamulu, Grace A. Otokpa, Bob A. Ukonu, Perpetua U. Ibekwe

01.04.2024 | Case report - Diagnosis

A challenging case of an adamantinoma of fibula with soft tissue mass harboring distinct histopathology

We present a case of adamantinoma that originated from the fibula and had a large soft tissue component measuring approximately 6 cm. Clinical, radiological, and pathological investigations initially suggested that the tumor might be a …

verfasst von:
Recep Öztürk, Umut Baran Zengin, Fisun Ardic Yukruk, Kemal Yücel, Furkan Öztürk, Kemal Kösemehmetoğlu

01.04.2024 | Case Report - Molecularly targeted therapy

Long-term response to MEK inhibitor monotherapy in a patient with papillary thyroid carcinoma harboring BRAF V600E mutation

Solid tumors harboring mutations in the Braf gene (BRAF) are currently treated by combination Braf/MEK inhibitor therapy, and there is an extensive literature on patient response rates. Alternatively, few studies have documented the clinical …

verfasst von:
Yuko Takano, Tomoya Shimokata, Hiroshi Urakawa, Toyone Kikumori, Yuichi Ando

30.03.2024 | Case report - Complication

An autopsy case of lung adenocarcinoma with immune checkpoint inhibitor-induced pneumonia and fulminant myocarditis following pembrolizumab administration: a case report

Immune checkpoint inhibitors (ICIs) are the current standard of care for non-small-cell lung cancer (NSCLC). Myocarditis is a rare but serious immune-related adverse event (irAE) associated with ICI therapy. We present a patient who received a …

verfasst von:
Takahiko Hashimoto, Kosuke Takahashi, Kosuke Ito, Kahori Iwade, Atsushi Torii, Minoru Sugihara, Haruka Kondo, Toru Hara

Open Access 29.03.2024 | Case Report - Complication

PD-L1 expression in keratinocyte and infiltration of CD4 + T lymphocyte can predict a severe type of erythema multiforme major induced by the anti-PD-1 antibody, pembrolizumab

Skin toxicity is the most common adverse event of treatment with immune check point inhibitors. Among them, erythema multiforme is a rare occurrence with a frequency of 4%, with most of the cases developing grade 1/2 disease. We experienced high …

verfasst von:
Ryohei Kadoi, Taichi Yoshida, Mai Noto, Aya Toyoshima, Sino Fujii, Koji Fukuda, Kazuhiro Shimazu, Daiki Taguchi, Hanae Shinozaki, Naoki Kodama, Michihiro Kono, Hiroshi Nanjyo, Hiroyuki Shibata

27.03.2024 | Case report - Complication

Cardiac-output response to exercise after allogeneic hematopoietic stem cell transplantation: a case report with a 2-year follow-up

Cardiac-output response to exercise was evaluated over a 2-year period in hematopoietic stem cell transplant recipients treated with cardiotoxic drugs. During the study period, resting cardiac function was normal; however, the cardiac output …

verfasst von:
Shinya Yoshida, Goro Sakurai, Tetsutaro Yahata

20.03.2024 | Case Report - Radiotherapy

Definitive chemoradiotherapy for a patient with anal cancer after renal transplantation

Patients after renal transplantation are susceptible to secondary malignancies, including anal squamous cell carcinoma. Chemoradiotherapy is the standard treatment for anal squamous cell carcinoma; however, typical irradiation fields for anal …

verfasst von:
Takeshi Kashiwagi, Katsuyuki Sakanaka, Hiroyuki Inoo, Hideaki Hirashima, Kota Fujii, Takashi Mizowaki

09.03.2024 | Case Report - Molecularly targeted therapy

Remarkable response to capmatinib in a patient with intrahepatic cholangiocarcinoma harboring TFG-MET fusion

Dysregulation of mesenchymal-epithelial transition factor (MET) gene due to amplification, mutation, and fusion has been reported in various types of human cancers. Recently, the efficacy of small-molecule tyrosine kinase inhibitors (TKIs) …

verfasst von:
Akira Ueta, Atsushi Yamada, Masahiro Yoshioka, Masashi Kanai, Manabu Muto, Natsuko Okita

09.03.2024 | Case Report - Molecularly targeted therapy

A case of treatment-resistant advanced gastric cancer with FGFR2 gene alteration successfully treated with pemigatinib

Comprehensive genome profiling (CGP) is expected to widen the scope of cancer drug options by identifying the genes involved in carcinogenesis. However, a few patients can access recommended treatments following CGP. Herein, we report a case in …

verfasst von:
Ryo Shinomiya, Yasushi Sato, Takanori Yoshimoto, Tomoyuki Kawaguchi, Akihiro Hirao, Koichi Okamoto, Yutaka Kawano, Masahiro Sogabe, Hiroshi Miyamoto, Tetsuji Takayama

Open Access 06.03.2024 | Case Report - Molecularly targeted therapy

EGFR-mutated lung adenocarcinoma with choroidal oligometastasis during treatment with gefitinib: a case report

The patient was a 74-year-old woman who was diagnosed with lung adenocarcinoma, clinical Stage IIIA. Induction chemoradiation was performed followed by right upper lobectomy and lymph node dissection. Because of positive pleural effusion cytology …

verfasst von:
Takafumi Hashimoto, Atsushi Osoegawa, Miyuki Abe, Ryoko Oki, Takashi Karashima, Yohei Takumi, Kosuke Kamada, Michiyo Miyawaki, Kenji Sugio

06.03.2024 | Case Report - Chemotherapy

Successful pre-surgical treatment with carboplatin and gemcitabine chemotherapy for a patient with muscle-invasive bladder cancer and severe renal dysfunction

Radical cystectomy is the standard treatment for muscle-invasive bladder cancer, and pre-surgical treatment can improve survival. Carboplatin and gemcitabine chemotherapy is considered an effective, safe treatment for patients ineligible for …

verfasst von:
Shota Torii, Tomoya Narita, Takamasa Homma, Teruhisa Kinoshita, Aya Torii-Goto, Hideki Esaki, Takashi Sakakibara, Atsuya Kondo, Norio Takimoto

24.10.2019 | Case report

Sinusoidal obstruction syndrome post-treatment with trastuzumab emtansine (T-DM1) in advanced breast cancer

Trastuzumab emtansine (T-DM1) is an antibody–drug conjugate approved for use in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer. Here, we present the cases of two patients with metastatic breast cancer …

verfasst von:
Yasutoshi Fujii, Mihoko Doi, Naofumi Tsukiyama, Yui Hattori, Kazuki Ohya, Noriyuki Shiroma, Kei Morio, Takehiko Morioka, Hiroshi Aikata, Katsunori Shinozaki, Kazuaki Chayama